Biotech · Private company · Monrovia, CA, US
Chromologic, LLC
Track this companyFree. Adds Chromologic, LLC to your Dealase workspace and tells you when its record changes.
Clinical trials0None registered
Pipeline programs0None found yet
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
NIH awards10
- Mitigation of Ionizing Irradiation-Induced Intestinal Damage by Second-Generation Probiotic LR-IFN-βFiscal year 2026 · $1MNIH RePORTER 5R42AI157357-04 · fetched Nov 12, 2026
- Investigation of the mechanisms of H-ARS mitigation by the orally administrated GI-ARS mitigator LR-IFN-betaFiscal year 2026 · $492.1KNIH RePORTER 5U01AI187044-02 · fetched Nov 12, 2026
- Validation of a microRNA panel to pre-symptomatically predict the risk of radiation-induced fibrosisFiscal year 2026 · $526.6KNIH RePORTER 5U01AI189450-02 · fetched Nov 12, 2026
- Development of Radiation/Nuclear Medical Countermeasures (MCMs) and Biodosimetry DevicesFiscal year 2026 · $639.8KNIH RePORTER 75N93023C00016-P00009-9999-1 · fetched Nov 12, 2026
- Development of engineered probiotic LR-IFN beta for GI-ARS mitigationFiscal year 2026 · $1.5MNIH RePORTER 75N93026C00008-0-9999-1 · fetched Nov 12, 2026
- Wearable Heat Related Injury Risk Analysis (WHERA) system ResubmissionFiscal year 2025 · $306.5KNIH RePORTER 1R43OH012965-01A1 · fetched Nov 12, 2026
- Investigation of the mechanisms of H-ARS mitigation by the orally administrated GI-ARS mitigator LR-IFN-betaFiscal year 2025 · $470.3KNIH RePORTER 1U01AI187044-01 · fetched Nov 12, 2026
- Validation of a microRNA panel to pre-symptomatically predict the risk of radiation-induced fibrosisFiscal year 2025 · $533.4KNIH RePORTER 1U01AI189450-01 · fetched Nov 12, 2026
- Mitigation of Ionizing Irradiation-Induced Intestinal Damage by Second-Generation Probiotic LR-IFN-βFiscal year 2025 · $1MNIH RePORTER 2R42AI157357-03A1 · fetched Nov 12, 2026
- NGS based metagenomic screening of ocular infectionsFiscal year 2025 · $898.4KNIH RePORTER 5R42EY033266-03 · fetched Nov 12, 2026